Use-result survey of FluMist intranasal spray

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2031240117

Enrollment

3000

Registered

2024-05-27

Start date

2024-09-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who fulfilled the following criteria at the time of registration 1) Subjects who are receiving FluMist intranasal spray for the first time to prevent Influenza virus infection 2) Subjects giving written consent from the study subjects or their guardians. 3) Subjects who are received FluMist intranasal spray during the contract period (contract period based on the contract with each medical site) 4) Subjects who are received FluMist intranasal spray during the registration period 5) Subjects who are 2 years old over and younger than 19 years old at the time of vaccination

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Safety Specifications and factors affecting safety in this study	—

Contacts

Public ContactGPSP Contact

Daiichi Sankyo Co.,Ltd.

contact_gpsp_jp@daiichisankyo.com+81-3-6225-1059

Outcome results